3 Feb 2017 acciones de biotecnología, Wall Street, mercados internacionales, bolsa Mientras el índice S&P 500 ganaba 50%, los ETFs más importantes de Nasdaq Biotechnology Index ETF (IBB) y el SPDR S&P Biotech ETF (XBI),  The investment seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the S&P 500® Index . The 

S&P Dow Jones Indices announced a delay to the quarterly rebalance of their equity indices, originally scheduled prior to market open on March 23, 2020, due   XBI · SPDR S&P Biotech ETF, Equity, Healthcare, $3,019.08, -27.33%, 6,771,458 FBT · First Trust Amex Biotechnology Index, Equity, Healthcare, $1,305.73  Oct 9, 2018 XBI fund managers aim to provide investors a similar total return to that of the S&P Biotechnology Select Industry Index, which is a subindustry  3 Feb 2017 acciones de biotecnología, Wall Street, mercados internacionales, bolsa Mientras el índice S&P 500 ganaba 50%, los ETFs más importantes de Nasdaq Biotechnology Index ETF (IBB) y el SPDR S&P Biotech ETF (XBI),  The investment seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the S&P 500® Index . The  Primary Benchmark, S&P 500 Buyback Index. CUSIP, 78468R820. Options Available, No. Gross Expense Ratio. Gross Expense Ratio. The fund's total annual 

XBI · SPDR S&P Biotech ETF, Equity, Healthcare, $3,019.08, -27.33%, 6,771,458 FBT · First Trust Amex Biotechnology Index, Equity, Healthcare, $1,305.73 

XBI · SPDR S&P Biotech ETF, Equity, Healthcare, $3,019.08, -27.33%, 6,771,458 FBT · First Trust Amex Biotechnology Index, Equity, Healthcare, $1,305.73  Oct 9, 2018 XBI fund managers aim to provide investors a similar total return to that of the S&P Biotechnology Select Industry Index, which is a subindustry  3 Feb 2017 acciones de biotecnología, Wall Street, mercados internacionales, bolsa Mientras el índice S&P 500 ganaba 50%, los ETFs más importantes de Nasdaq Biotechnology Index ETF (IBB) y el SPDR S&P Biotech ETF (XBI),  The investment seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the S&P 500® Index . The 

XBI · SPDR S&P Biotech ETF, Equity, Healthcare, $3,019.08, -27.33%, 6,771,458 FBT · First Trust Amex Biotechnology Index, Equity, Healthcare, $1,305.73 

Oct 9, 2018 XBI fund managers aim to provide investors a similar total return to that of the S&P Biotechnology Select Industry Index, which is a subindustry  3 Feb 2017 acciones de biotecnología, Wall Street, mercados internacionales, bolsa Mientras el índice S&P 500 ganaba 50%, los ETFs más importantes de Nasdaq Biotechnology Index ETF (IBB) y el SPDR S&P Biotech ETF (XBI),  The investment seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the S&P 500® Index . The 

Oct 9, 2018 XBI fund managers aim to provide investors a similar total return to that of the S&P Biotechnology Select Industry Index, which is a subindustry 

Performance charts for SPDR S&P Biotech ETF (XBI - Type ETF) including intraday, of the S&P Biotechnology Select Industry Index, an equal-weighed index. S&P Dow Jones Indices announced a delay to the quarterly rebalance of their equity indices, originally scheduled prior to market open on March 23, 2020, due   XBI · SPDR S&P Biotech ETF, Equity, Healthcare, $3,019.08, -27.33%, 6,771,458 FBT · First Trust Amex Biotechnology Index, Equity, Healthcare, $1,305.73  Oct 9, 2018 XBI fund managers aim to provide investors a similar total return to that of the S&P Biotechnology Select Industry Index, which is a subindustry 

Primary Benchmark, S&P 500 Buyback Index. CUSIP, 78468R820. Options Available, No. Gross Expense Ratio. Gross Expense Ratio. The fund's total annual 

Performance charts for SPDR S&P Biotech ETF (XBI - Type ETF) including intraday, of the S&P Biotechnology Select Industry Index, an equal-weighed index. S&P Dow Jones Indices announced a delay to the quarterly rebalance of their equity indices, originally scheduled prior to market open on March 23, 2020, due   XBI · SPDR S&P Biotech ETF, Equity, Healthcare, $3,019.08, -27.33%, 6,771,458 FBT · First Trust Amex Biotechnology Index, Equity, Healthcare, $1,305.73  Oct 9, 2018 XBI fund managers aim to provide investors a similar total return to that of the S&P Biotechnology Select Industry Index, which is a subindustry  3 Feb 2017 acciones de biotecnología, Wall Street, mercados internacionales, bolsa Mientras el índice S&P 500 ganaba 50%, los ETFs más importantes de Nasdaq Biotechnology Index ETF (IBB) y el SPDR S&P Biotech ETF (XBI),  The investment seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the S&P 500® Index . The  Primary Benchmark, S&P 500 Buyback Index. CUSIP, 78468R820. Options Available, No. Gross Expense Ratio. Gross Expense Ratio. The fund's total annual 

Performance charts for SPDR S&P Biotech ETF (XBI - Type ETF) including intraday, of the S&P Biotechnology Select Industry Index, an equal-weighed index. S&P Dow Jones Indices announced a delay to the quarterly rebalance of their equity indices, originally scheduled prior to market open on March 23, 2020, due   XBI · SPDR S&P Biotech ETF, Equity, Healthcare, $3,019.08, -27.33%, 6,771,458 FBT · First Trust Amex Biotechnology Index, Equity, Healthcare, $1,305.73  Oct 9, 2018 XBI fund managers aim to provide investors a similar total return to that of the S&P Biotechnology Select Industry Index, which is a subindustry  3 Feb 2017 acciones de biotecnología, Wall Street, mercados internacionales, bolsa Mientras el índice S&P 500 ganaba 50%, los ETFs más importantes de Nasdaq Biotechnology Index ETF (IBB) y el SPDR S&P Biotech ETF (XBI),